The University of Vale do Itajaí (Univali) is officially joining the group of institutions authorized by the National Health Surveillance Agency (Anvisa) to perform analyses of Cannabis-derived products.

The authorization is stated in Resolution-RE No. 4,076, published in the Official Gazette of October 20, 2025. This measure expands the university's scope within the Brazilian Network of Analytical Health Laboratories (Reblas).

The measure follows a recent guideline from the agency. Since September 8, 2025, analytical laboratories, whether public or private, authorized by Anvisa, are officially authorized to perform analyses of cannabis products.

Quality control in cannabis products

The authorization allows Univali to perform quality control tests on Cannabis-based products, as provided for in Article 5 of Resolution RDC No. 928/2024. This action reinforces the university's commitment to the safety, efficacy, and reliability of these compounds in the national market.

"This authorization represents a milestone for applied research and the strengthening of the national scientific network," says Pharmaceutical Technology specialist Professor Ruth Meri Lucinda.

"Univali has the structure, technical knowledge, and experience to contribute with high-precision analyses, offering support to public policies and the demands of Cannabis associations," adds the professor.

Promotion of research

In addition to consolidating the university's presence in Reblas, the new authorization paves the way for more comprehensive studies on bioactive compounds and potential therapeutic effects of cannabinoids.

According to Professor Márcia Maria de Souza, a researcher in Experimental Pharmacology, Univali has already been conducting pre-clinical investigations. These studies involve synthetic and/or natural cannabinoids with an emphasis on epilepsy and autism models.

"Furthermore, we have been deepening the discussion on medicinal Cannabis in events held both by our university and by partner institutions of the ACAFE system, consolidating academic engagement over the past years," says Márcia.

Safety and access in the cannabis market

Professor Márcia also highlights the social impact of the authorization, aiming for greater safety for patients using Cannabis products.

"The country still faces barriers to ensure access to safe and properly analyzed products. This advancement is a decisive step to strengthen society's confidence and support associations fighting for technical quality validations," she adds.

The new authorization reinforces Univali's position as a reference in science, innovation, and social impact in Southern Brazil. The institution maintains laboratories with certified infrastructure, researchers with a solid academic background, and a history of collaboration in projects in the areas of phytochemistry, pharmacology, and biotechnology.

"Our interest is to engage in conversations that promote the advancement of knowledge and consumer safety. This is an achievement not only for the university but for the entire scientific community acting responsibly on this subject," concludes Ruth.